文献速递慢性肾脏病肾小球疾病肾血管病与高血压

Bardet-Biedl综合征中的慢性肾脏病:多因素病因学证据

CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial Etiology.
PubMed 文献 · Kidney Int Rep · 2024-11-06

该单中心横断面研究纳入65例Bardet-Biedl综合征患者,25%患者eGFR<60 ml/min per 1.73 m2,年龄与eGFR呈负相关(P=0.002),截短突变和高血压与eGFR降低显著相关,BMI独立关联eGFR下降(β=-2.45,P<0.0001),提示年龄、高血压和肥胖与成人BBS患者eGFR下降相关。

要点

  • BBS患者中25%存在eGFR<60 ml/min per 1.73 m2。
  • 年龄增长与eGFR下降相关(P=0.002)。
  • 截短突变和高血压与eGFR降低显著相关。

核心结论

  • BBS是易患肾脏疾病的疾病状态,年龄、高血压和肥胖与成人BBS患者eGFR下降相关。

研究设计与样本

  • 单中心横断面研究,纳入65例BBS患者,进行下一代测序遗传分析和肾功能评估。

主要发现

  • 25%患者eGFR<60 ml/min per 1.73 m2。
  • 年龄与eGFR呈负相关(P=0.002)。
  • eGFR降低与任何BBS基因的截短突变和高血压显著相关。
  • 多变量分析显示BMI独立关联eGFR下降(β=-2.45,P<0.0001),年龄亦独立关联。
  • 50%共享相同致病突变的近亲或非近亲患者亚组显示肾脏表型显著不一致。

临床怎么用

  • 对BBS患者应关注年龄、高血压和肥胖等可干预因素,以评估CKD风险。

局限性

  • 研究为横断面设计,无法确定因果关系。
  • 有效干预可改变因素是否降低CKD风险需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Chronic kidney disease (CKD) is a critical prognostic factor in Bardet-Biedl syndrome (BBS). Early diagnosis and intervention are essential for improving patient outcomes. The present study analyzed kidney function in patients with BBS, with the aim to explore the impact of genetic variants and common risk factors for kidney disease. METHODS: A monocentric cross-sectional study was conducted. Patients underwent genetic analysis via next generation sequencing; renal function was assessed and the relationship with the following: (i) age, obesity, hypertension and (ii) genetic mutations was analyzed. RESULTS: A total of 65 patients with BBS were enrolled in the study; renal function was variable, with 25% of patients showing an estimated glomerular filtration rate (eGFR) < 60 ml/min per 1.73 m2. Patients' age was inversely correlated with the eGFR (P = 0.002). Reduced eGFR significantly correlated with truncating mutations in any BBS gene and hypertension; moreover, multivariate analysis using eGFR as an objective variable and multiple risk factors as explanatory variables, showed that body mass index (BMI) was independently associated with eGFR decline (β = -2.45, P < 0.0001), in addition to age. Interestingly, significant discordance in renal phenotype was revealed in 50% of subgroups of consanguineous or nonconsanguineous patients sharing the same pathogenic variants, indicating clinical variability even in this setting. CONCLUSION: The present study suggests that BBS is a condition of vulnerability to develop kidney disease, and that age, hypertension and obesity are associated with eGFR decline in adult patients with BBS. Whether effective interventions to treat modifiable factors will reduce CKD risk requires further studies.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Zacchia M, Secondulfo F, Melluso A, et al. CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial Etiology. Kidney Int Rep. 2024. PMID: 39990901. doi:10.1016/j.ekir.2024.10.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。